It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on these events and ensure that drugs are safe in everyday use?
One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals. And that statistic begs a crucial question: How can we really ensure patients’ safety in an age of sophisticated medications and accelerated approval processes?
New Biosimilar Switching Paper Prioritizes Physician-Patient Relationship and Robust Pharmacovigilance
A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates across Europe.
As more biosimilars become available globally, clinicians are eager to understand: How does switching between biological medicines affect patients?